Feasibility of Bariatric Surgery in the HIV-Infected Patients

Kassir, Radwan; Huart, Eve; Tiffet, Olivier; Frésard, A.; Lucht, F.; Gagneux‐Brunon, Amandine; Botelho-Nevers, Élisabeth

doi:10.1007/s11695-016-2538-9

Cited by 5 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In all three cases, HIV status was not affected by bariatric surgery, which is consistent with existing literature [4, 6, 11, 12, 15]. There is a theoretical concern over drug absorption following bariatric surgery.…”

Section: Discussionsupporting

confidence: 88%

“…In conclusion, our case series further supports the use of bariatric surgery as a safe treatment modality in individuals who are HIV positive [11]. Importantly, we have demonstrated the positive effect of bariatric surgery on T2DM in this group of patients.…”

Section: Discussionsupporting

confidence: 78%

“…Despite this, bariatric surgery remains an underutilized tool and data are limited for the HIV-infected population. Although reports [11, 12] have suggested that bariatric surgery is safe, there is a paucity of data describing the outcomes of T2DM in these individuals or, in fact, the uptake of surgery.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Bariatric surgery in individuals with human immunodeficiency virus and type 2 diabetes: a case series

et al. 2019

View full text Add to dashboard Cite

Background The efficacy and safety of bariatric surgery have not been fully elucidated in patients affected with human immunodeficiency virus. Although adjustable gastric banding and sleeve gastrectomy are starting to be used in patients with human immunodeficiency virus, there are limited descriptions of the outcomes of type 2 diabetes mellitus in individuals who are human immunodeficiency virus positive and undergoing these procedures. Case presentation We have evaluated retrospectively three patients who underwent adjustable gastric banding or sleeve gastrectomy, the effect in weight reduction and glycemic control as well as its impact on human immunodeficiency virus management. Case 1 (adjustable gastric banding), a 58-year-old Caucasian male, achieved 19% total weight loss, Case 2, a 33-year-old Caucasian male (sleeve gastrectomy) lost 25%, and Case 3, a 48-year-old Caucasian female (sleeve gastrectomy), lost 14% postoperation. In terms of type 2 diabetes mellitus, Case 2 achieved complete remission according to American Diabetes Association criteria, while Case 1 would also have achieved remission were it not for the continuation of metformin postoperatively. Insulin requirements and pill burden were markedly reduced in Case 3 after sleeve gastrectomy, although lack of remission was predictable given the longevity of type 2 diabetes mellitus and preoperative insulin dosage. In all three cases, human immunodeficiency virus status did not appear to be affected by the bariatric surgery which was supported by the postoperative stable CD4 count and undetectable viral load. Conclusions Bariatric surgery is a safe and effective treatment modality in patients who are human immunodeficiency virus positive with obesity and type 2 diabetes mellitus.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionsupporting

confidence: 78%

See 1 more Smart Citation

Bariatric surgery in individuals with human immunodeficiency virus and type 2 diabetes: a case series

et al. 2019

View full text Add to dashboard Cite

show abstract

“…While studies have evaluated bariatric surgery in this unique patient population and found the procedure to be safe and effective, there remains a paucity of data regarding the impact of bariatric surgery on outcomes of patients with HIV. 8,10…”

Section: Introductionmentioning

confidence: 99%